Cabenuva has been shown to be effective at controlling HIV in clinical trials.

It is generally well tolerated, with the most common side effects being injection site reactions and flu-like symptoms.

It is important for people taking Cabenuva to have regular follow-up appointments with their healthcare provider to monitor their HIV levels and check for any side effects.

It is important to note that Cabenuva is not recommended for people who are resistant to cabotegravir or rilpivirine, or for people who have certain types of liver problems.

It is also not recommended for use in pregnant women, as the safety of the medication in pregnancy has not been established.

The drug costs slightly less than 40, 000 USD.

Even though it’s high cost the drug has been said to be effective and will save several lives.